| RS2509299907 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS2509299991 |
CHRNE
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS2509300003 |
CHRNE
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS2509300481 |
RAD51C
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2509300511 |
RAD51C
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2509300604 |
RAD51C
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2509301277 |
DGKE
|
Health Risk |
Likely pathogenic |
— |
| RS2509305424 |
SCN4A
|
Health Risk |
Likely pathogenic |
SCN4A-related disorder, SCN4A-related disorder |
| RS2509307905 |
COQ7
|
Health Risk |
Conflicting classifications of pathogenicity |
COQ7-related disorder, COQ7-related disorder |
| RS2509308046 |
SCN4A
|
Health Risk |
Pathogenic |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS2509308079 |
COQ7
|
Health Risk |
Likely pathogenic |
Primary coenzyme Q10 deficiency 8, Primary coenzyme Q10 deficiency 8 |
| RS2509312694 |
RAD51C
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2509312994 |
RAD51C
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group O, Fanconi anemia complementation group O |
| RS2509312999 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2509313550 |
RAD51C
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2509313565 |
RAD51C
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS2509313576 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS2509313987 |
SCN4A
|
Health Risk |
Likely pathogenic |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS2509314301 |
SCN4A
|
Health Risk |
Pathogenic |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS2509315709 |
SCN4A
|
Health Risk |
Pathogenic |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS2509317969 |
SCN4A
|
Health Risk |
Pathogenic |
Congenital myopathy 22B, severe fetal |
| RS2509318035 |
SCN4A
|
Health Risk |
Pathogenic |
Congenital myopathy 22A, classic |
| RS2509318698 |
SCN4A
|
Health Risk |
Pathogenic |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS2509324687 |
SCN4A
|
Health Risk |
Likely pathogenic |
SCN4A-related disorder, SCN4A-related disorder |
| RS2509325722 |
SCN4A
|
Health Risk |
Likely pathogenic |
SCN4A-related disorder, SCN4A-related disorder |
| RS2509336795 |
RAD51C
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2509336958 |
RAD51C
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2509337046 |
RAD51C
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2509337177 |
RAD51C
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2509337492 |
RAD51C
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group O, Fanconi anemia complementation group O |
| RS2509339083 |
RNF43
|
Health Risk |
Pathogenic |
Sessile serrated polyposis cancer syndrome, Sessile serrated polyposis cancer syndrome |
| RS2509343002 |
RNF43
|
Health Risk |
Conflicting classifications of pathogenicity |
Sessile serrated polyposis cancer syndrome, Sessile serrated polyposis cancer syndrome |
| RS2509343899 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Breast-ovarian cancer |
| RS2509343956 |
RAD51C
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2509344172 |
RAD51C
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2509344423 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS2509344483 |
RAD51C
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2509344581 |
RAD51C
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2509344663 |
RAD51C
|
Health Risk |
Likely pathogenic |
Gastric cancer, Breast-ovarian cancer |
| RS2509348557 |
COQ7
|
Health Risk |
Pathogenic |
Neuronopathy, distal hereditary motor |
| RS2509349181 |
COQ7
|
Health Risk |
Pathogenic |
Primary coenzyme Q10 deficiency 8, Primary coenzyme Q10 deficiency 8 |
| RS2509357138 |
PRKAR1A
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2509357240 |
CLTC
|
Health Risk |
Pathogenic |
— |
| RS2509357386 |
CLTC
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 56 |
| RS2509357398 |
G6PC3
|
Health Risk |
Pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS2509357401 |
G6PC3
|
Health Risk |
Pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS2509357631 |
STAT3
|
Health Risk |
Likely pathogenic |
— |
| RS2509357939 |
G6PC3
|
Health Risk |
Pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS2509359618 |
RNF43
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2509361365 |
CLTC
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 56 |
| RS2509361452 |
CLTC
|
Health Risk |
Likely pathogenic |
CLTC-related disorder, CLTC-related disorder |
| RS2509363884 |
RAD51C
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2509363942 |
RAD51C
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2509363977 |
RGS9
|
Health Risk |
Likely pathogenic |
— |
| RS2509364075 |
RGS9
|
Health Risk |
Likely pathogenic |
— |
| RS2509364078 |
RAD51C
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group O, Breast-ovarian cancer |
| RS2509364261 |
G6PC3
|
Health Risk |
Pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS2509364267 |
RAD51C
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group O, Fanconi anemia complementation group O |
| RS2509364519 |
G6PC3
|
Health Risk |
Likely pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS2509364523 |
G6PC3
|
Health Risk |
Likely pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS2509365373 |
CLTC
|
Health Risk |
Pathogenic |
— |
| RS2509366238 |
RNF43
|
Health Risk |
Conflicting classifications of pathogenicity |
Sessile serrated polyposis cancer syndrome, Sessile serrated polyposis cancer syndrome |
| RS2509366840 |
RGS9
|
Health Risk |
Likely pathogenic |
— |
| RS2509368564 |
RGS9
|
Health Risk |
Likely pathogenic |
— |
| RS2509369208 |
G6PC3
|
Health Risk |
Likely pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS2509369429 |
G6PC3
|
Health Risk |
Pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS2509369753 |
RAD51C
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group O, Fanconi anemia complementation group O |
| RS2509371071 |
CLTC
|
Health Risk |
Likely pathogenic |
— |
| RS2509371353 |
G6PC3
|
Health Risk |
Likely pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS2509371931 |
G6PC3
|
Health Risk |
Pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS2509372929 |
COQ7
|
Health Risk |
Pathogenic |
Primary coenzyme Q10 deficiency 8, Primary coenzyme Q10 deficiency 8 |
| RS2509376984 |
COX11
|
Health Risk |
Pathogenic |
Mitochondrial complex IV deficiency, nuclear type 23 |
| RS2509378628 |
CLTC
|
Health Risk |
Pathogenic |
— |
| RS2509378785 |
CLTC
|
Health Risk |
Pathogenic |
— |
| RS2509380645 |
HDC
|
Health Risk |
Likely pathogenic |
Tourette syndrome, Tourette syndrome |
| RS2509383539 |
CLTC
|
Health Risk |
Pathogenic |
— |
| RS2509384180 |
CLTC
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 56 |
| RS2509384283 |
CLTC
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 56 |
| RS2509384644 |
CLTC
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 56 |
| RS2509384754 |
CLTC
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2509387175 |
RNF43
|
Health Risk |
Pathogenic |
— |
| RS2509389531 |
AXIN2
|
Health Risk |
Pathogenic/Likely pathogenic |
AXIN2-related disorder, Hereditary cancer-predisposing syndrome |
| RS2509389560 |
AXIN2
|
Health Risk |
Pathogenic |
Oligodontia-cancer predisposition syndrome, Oligodontia-cancer predisposition syndrome |
| RS2509389582 |
AXIN2
|
Health Risk |
Pathogenic |
Oligodontia-cancer predisposition syndrome, Oligodontia-cancer predisposition syndrome |
| RS2509390675 |
STAT3
|
Health Risk |
Likely pathogenic |
STAT3-related disorder, STAT3-related disorder |
| RS2509391041 |
STAT3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2509391311 |
STAT3
|
Health Risk |
Pathogenic |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS2509394487 |
STAT3
|
Health Risk |
Likely pathogenic |
— |
| RS2509396464 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Oligodontia-cancer predisposition syndrome |
| RS2509396878 |
AXIN2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2509396943 |
AXIN2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2509397080 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Oligodontia-cancer predisposition syndrome |
| RS2509397361 |
AXIN2
|
Health Risk |
Likely pathogenic |
Colorectal cancer, Colorectal cancer |
| RS2509397413 |
AXIN2
|
Health Risk |
Pathogenic |
Oligodontia-cancer predisposition syndrome, Oligodontia-cancer predisposition syndrome |
| RS2509397598 |
AXIN2
|
Health Risk |
Likely pathogenic |
Oligodontia-cancer predisposition syndrome, Oligodontia-cancer predisposition syndrome |
| RS2509398263 |
PRKAR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Carney complex, type 1 |
| RS2509399227 |
PRKAR1A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2509401757 |
AXIN2
|
Health Risk |
Likely pathogenic |
Oligodontia-cancer predisposition syndrome, Oligodontia-cancer predisposition syndrome |
| RS2509402115 |
AXIN2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2509402190 |
AXIN2
|
Health Risk |
Pathogenic |
Oligodontia-cancer predisposition syndrome, Oligodontia-cancer predisposition syndrome |